UniProtKB/SwissProt variant VAR

Variant information

Variant position:

39

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Arginine (R) to Histidine (H) at position 39 (R39H, p.Arg39His).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (H)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

0

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Involvement in disease:

Aortic aneurysm, familial thoracic 6 (AAT6) [MIM:611788]: A disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. {ECO:0000269|PubMed:17994018, ECO:0000269|PubMed:19409525, ECO:0000269|PubMed:19639654}. Note=The disease is caused by mutations affecting the gene represented in this entry.

The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:

In AAT6.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs794728021 [ dbSNP | Ensembl ]

Sequence information

Variant position:

39

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

377

The length of the canonical sequence.

Location on the sequence:

CKAGFAGDDAPRAVFPSIVG R PRHQGVMVGMGQKDSYVGDE

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Mouse                         CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Rat                           CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Bovine                        CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Rabbit                        CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Chicken                       CKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 377	Actin, aortic smooth muscle, intermediate form
Chain	3 – 377	Actin, aortic smooth muscle
Modified residue	46 – 46	Methionine (R)-sulfoxide
Modified residue	49 – 49	Methionine (R)-sulfoxide
Cross	52 – 52	Isoglutamyl lysine isopeptide (Lys-Glu) (interchain with E-272); by Vibrio toxins RtxA and VgrG1

Literature citations

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.
Guo D.-C.; Papke C.L.; Tran-Fadulu V.; Regalado E.S.; Avidan N.; Johnson R.J.; Kim D.H.; Pannu H.; Willing M.C.; Sparks E.; Pyeritz R.E.; Singh M.N.; Dalman R.L.; Grotta J.C.; Marian A.J.; Boerwinkle E.A.; Frazier L.Q.; LeMaire S.A.; Coselli J.S.; Estrera A.L.; Safi H.J.; Veeraraghavan S.; Muzny D.M.; Wheeler D.A.; Willerson J.T.; Yu R.K.; Shete S.S.; Scherer S.E.; Raman C.S.; Buja L.M.; Milewicz D.M.;
Am. J. Hum. Genet. 84:617-627(2009)
Cited for: VARIANTS AAT6 HIS-39; THR-117; GLN-118; CYS-149; ALA-154; GLN-185; GLN-212; HIS-258; CYS-258; ASN-326 AND ASN-353;

UniProtKB/Swiss-Prot P62736: Variant p.Arg39His